Authors
Liyong Zhuo, Wenjing Chen, Zijun Song, Lihong Xing, Xiaomeng Li, Jiawei Hao, Zimei Yang, Xuechun Wang, Caiying Li, Jianing Wang, Xiaoping Yin
Published in
Insights into imaging. Volume 17. Issue 1. Jul 22, 2026. Epub Jul 22, 2026.
Abstract
To develop an interpretable magnetic resonance imaging (MRI)-based framework for preoperative histologic grading of intrahepatic mass-forming cholangiocarcinoma (IMCC) and exploratory prognostic stratification.
A retrospective analysis was conducted on preoperative MRI from 333 IMCC patients across three centers (training cohort, n = 240; external validation cohort, n = 93). An ensemble deep learning (DL) framework synergizing 2.5D and 3D ResNet-50 architectures was constructed. Significant variables from clinical-laboratory-imaging (ClinLabImag) features, radiomics, and DL outputs were integrated into a combined model. Discrimination was assessed using the area under the receiver operating characteristic curve (AUC). Model interpretability was evaluated with Gradient-weighted Class Activation Mapping (Grad-CAM) and SHapley Additive exPlanations (SHAP), and the Kaplan-Meier method was used to compare overall survival (OS) between risk groups.
The DL model achieved an external validation AUC of 0.804 (95% confidence interval (CI): 0.712-0.896), significantly outperforming standalone 2.5D (p = 0.025) and 3D architectures (p = 0.030). The Combined model (AUC: 0.843 [95% CI, 0.749-0.938]) showed better external validation performance than the Radiomics (p = 0.019) and ClinLabImag models (p = 0.017), with only modest, non-significant improvement over the DL model (p = 0.355). SHAP analysis showed that DL features contributed most to model predictions. The Combined model showed exploratory OS differences between risk groups.
An interpretable multidimensional MRI-based DL framework supports noninvasive preoperative grading in IMCC and provides exploratory prognostic information.
This study critically evaluates an interpretable multidimensional MRI-based deep learning framework for preoperative grading and exploratory prognostic stratification of intrahepatic mass-forming cholangiocarcinoma, supporting individualized radiologic risk assessment before treatment.
Reliable noninvasive MRI biomarkers are needed for preoperative grading and prognostic assessment of intrahepatic mass-forming cholangiocarcinoma to guide individualized treatment planning. The combined multidimensional MRI model achieved favorable external validation performance and showed exploratory overall survival differences between IMCC risk groups.
PMID:
42484736
Bibliographic data and abstract were imported from PubMed on 22 Jul 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 8
- Comments 0